helping prevent relapse of a rare form of cancer
While at Boundless Life Sciences, I developed and wrote creative concepts to launch iwilfin, an oral tablet shown to reduce the risk of relapse of high-risk neuroblastoma, a rare form of cancer that primarily affects children.
For impact and memorability, we played directly off of the name of the drug, iwilfin, to highlight the determination of HCPs and caregivers to do all they can for their very young patients. Here are adlobs of what proved to be the winning concept in a unified campaign, with versions for HCPs and patients.
For impact and memorability, we played directly off of the name of the drug, iwilfin, to highlight the determination of HCPs and caregivers to do all they can for their very young patients. Here are adlobs of what proved to be the winning concept in a unified campaign, with versions for HCPs and patients.
the "I WILL" concept as it is used in practice:
Note: the samples of work product shown here are not owned by me; they are presented solely to demonstrate my creativity while working for various employers.
